Annual Current Liabilities
$95.19 M
+$21.57 M+29.30%
31 December 2023
Summary:
Xeris Biopharma Holdings annual total current liabilities is currently $95.19 million, with the most recent change of +$21.57 million (+29.30%) on 31 December 2023. During the last 3 years, it has risen by +$66.99 million (+237.48%). XERS annual current liabilities is now at all-time high.XERS Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$91.01 M
+$15.53 M+20.57%
30 September 2024
Summary:
Xeris Biopharma Holdings quarterly total current liabilities is currently $91.01 million, with the most recent change of +$15.53 million (+20.57%) on 30 September 2024. Over the past year, it has increased by +$3.97 million (+4.57%). XERS quarterly current liabilities is now -4.39% below its all-time high of $95.19 million, reached on 31 December 2023.XERS Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XERS Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +29.3% | +4.6% |
| 3 y3 years | +237.5% | +144.1% |
| 5 y5 years | +835.8% | +411.5% |
XERS Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +237.5% | -4.4% | +144.1% |
| 5 y | 5 years | at high | +835.8% | -4.4% | +411.5% |
| alltime | all time | at high | +3667.0% | -4.4% | +1772.7% |
Xeris Biopharma Holdings Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $91.01 M(+20.6%) |
| June 2024 | - | $75.49 M(+3.3%) |
| Mar 2024 | - | $73.08 M(-23.2%) |
| Dec 2023 | $95.19 M(+29.3%) | $95.19 M(+9.4%) |
| Sept 2023 | - | $87.04 M(+9.2%) |
| June 2023 | - | $79.68 M(-2.1%) |
| Mar 2023 | - | $81.42 M(+10.6%) |
| Dec 2022 | $73.62 M(-6.9%) | $73.62 M(+7.4%) |
| Sept 2022 | - | $68.56 M(+6.2%) |
| June 2022 | - | $64.55 M(-2.9%) |
| Mar 2022 | - | $66.49 M(-15.9%) |
| Dec 2021 | $79.04 M | $79.04 M(+112.0%) |
| Sept 2021 | - | $37.28 M(+5.1%) |
| June 2021 | - | $35.46 M(+29.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $27.42 M(-2.8%) |
| Dec 2020 | $28.21 M(+3.2%) | $28.21 M(+4.4%) |
| Sept 2020 | - | $27.03 M(+18.6%) |
| June 2020 | - | $22.79 M(+4.1%) |
| Mar 2020 | - | $21.88 M(-20.0%) |
| Dec 2019 | $27.34 M(+168.8%) | $27.34 M(+53.7%) |
| Sept 2019 | - | $17.79 M(-15.3%) |
| June 2019 | - | $21.01 M(+56.7%) |
| Mar 2019 | - | $13.41 M(+31.8%) |
| Dec 2018 | $10.17 M(+109.3%) | $10.17 M(+23.9%) |
| Sept 2018 | - | $8.21 M(-10.7%) |
| June 2018 | - | $9.19 M(-0.0%) |
| Mar 2018 | - | $9.19 M(+89.1%) |
| Dec 2017 | $4.86 M(+92.3%) | $4.86 M |
| Dec 2016 | $2.53 M | - |
FAQ
- What is Xeris Biopharma Holdings annual total current liabilities?
- What is the all time high annual current liabilities for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings annual current liabilities year-on-year change?
- What is Xeris Biopharma Holdings quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings quarterly current liabilities year-on-year change?
What is Xeris Biopharma Holdings annual total current liabilities?
The current annual current liabilities of XERS is $95.19 M
What is the all time high annual current liabilities for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high annual total current liabilities is $95.19 M
What is Xeris Biopharma Holdings annual current liabilities year-on-year change?
Over the past year, XERS annual total current liabilities has changed by +$21.57 M (+29.30%)
What is Xeris Biopharma Holdings quarterly total current liabilities?
The current quarterly current liabilities of XERS is $91.01 M
What is the all time high quarterly current liabilities for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high quarterly total current liabilities is $95.19 M
What is Xeris Biopharma Holdings quarterly current liabilities year-on-year change?
Over the past year, XERS quarterly total current liabilities has changed by +$3.97 M (+4.57%)